chrisvoncsefalvay/vaers-outcomes huggingface dataset:
About 8 days after receiving the Moderna booster, I began noticing red, itchy hives appearing in random parts of my body. I visited the ER on day 13 after the vaccine for fear of a food allergy, and was prescribed 5 days of prednisone. This helped control the hives and reduce itching. After the 5-day regimen of prednisone, I have continued taking Zyrtec daily. The hives continue appearing in random parts of my body and then disappearing after ~15-20 minutes, although they no longer itch. This pattern has not changed as of Jan 9, 2022 (3 weeks since stopping prednisone, 6 weeks since receiving vaccine booster).
woke up today with a horrible shooting pain down her right side that starts at the hip & goes down to the ankle; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (woke up today with a horrible shooting pain down her right side that starts at the hip & goes down to the ankle) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 066K21A) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Mar-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Mar-2022, the patient experienced PAIN (woke up today with a horrible shooting pain down her right side that starts at the hip & goes down to the ankle). At the time of the report, PAIN (woke up today with a horrible shooting pain down her right side that starts at the hip & goes down to the ankle) outcome was unknown.            No concomitant medication was reported. Shooting pain felt down her right side that starts at the hip & went down to the ankle. The same pain was felt after her 2nd dose that lasted about a month & got better after patient went to a walk-in orthopedic clinic and got a steroid injection. No treatment medication was reported.   This case was linked to MOD-2022-525796 (Patient Link).
2 hrs after the shot staff feel weakness, swelling face, body ache.  Body-ache was getting so bad that she had to take or apply over the counter pain killer.  Next morning, headache continue to be very bad that she was having nausea, vomiting, chill and cough.  She is feeling better now.
Fever (100 - 101 degrees F), Body aches, Fatigue, Chills, Headache, Nausea. Started at 9 am the day after my shot Thurs April 22 and continued through @ 2-3 am Fri Apr 23rd.
Rash (maculo/papular) on right shoulder and upper arm area also high fever 101.2.
SWOLLEN LYMPH NODES; DISCOLORATION ON THE INJECTION SITE (BIG BRUISE); PAIN; VOMITING; HEADACHE; NAUSEA; FATIGUE; This spontaneous report received from a parent concerned a female of unspecified age. The patient's height, and weight were not reported. The patient's past medical history included brain aneurysm. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805029, and expiry: UNKNOWN) dose was not reported, administered on 13-MAR-2021 for prophylactic vaccination. No concomitant medications were reported.  On 13-MAR-2021, the subject experienced swollen lymph nodes. On 13-MAR-2021, the subject experienced discoloration on the injection site (big bruise). On 13-MAR-2021, the subject experienced pain. On 13-MAR-2021, the subject experienced vomiting. On 13-MAR-2021, the subject experienced headache. On 13-MAR-2021, the subject experienced nausea. On 13-MAR-2021, the subject experienced fatigue. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from headache, pain, vomiting, swollen lymph nodes, discoloration on the injection site (big bruise), nausea, and fatigue. This report was non-serious.
Cough and Nasal congestion. MEDI-0003727 is a non serious spontaneous case from a consumer in the USA involving cough:(Labelled, USA, ). The reporter causality is not provided to FluMist. This case is submitted according to the VAERS Safety Surveillance accelerated reporting agreement for FluMist. A consumer reported that her 5 year old son experienced cough and nasal congestion 4 days after receiving FluMist vaccine on 28Sep05.  The patient has not yet recovered at this time. Earlier, the reporter called in an adverse event report involving her own symptoms after she received FluMist vaccine. The reporter causality is not provided.  Follow-up information received 01-18-2010. Lot number information obtained from reporter.
Extreme dizziness for 24 hours, followed by aches, exhaustion, chills, headache, nausea day 2, horrible headache day  3 plus exhaustion, day 4 weak but starred feeling much better by Friday after the shot on zoo day afternoon.  Dizziness of a milder nature returned along with headache on 4/6 and went into a horrible headache 4/7 that wouldn?t stop  along with nausea.  Headache is still here today but I can live with it, nausea still here but not as bad.  I DREAD GETTING THE 2ND shot!
BIB mother, c/o left thigh pain and swelling after immunization shots 5 days ago. Prescribed loratadine 5mg/5mL oral syrup = 5 mL, ORAL, DAILY, #150 mL, 3 Refill(s) Maintenance. Differential Diagnosis: Superficial thrombophlebitis, cellulitis, allergic reaction. Rationale: Left thigh is to have local reaction to the immunization she received. Mild warmth and tenderness we'll add Keflex to cover local cellulitis. Duffel. Motrin for pain ice and Benadryl.
Side effects within first 3 days included extreme sore arm (muscle), temperature, aching, headache, heart palpitations, dizziness, fatigue and difficulty concentrating.  However, 5 weeks later I am still experiencing extreme fatigue, tiredness, as well as heaviness in chest.
This spontaneous report was received from a pharmacist  and refers to a four unspecified patients of unknown ages and genders. The patient's concurrent conditions, medical histories and concomitant therapies were not reported. On an unknown date, the patient was vaccinated with improperly stored LIQUID PEDVAXHIB, which had a lot # reported as "N045206", expiration date of 27-JUN-2019, for prophylaxis. Temperature: 47°F to 77°F (64F) Time frame: 8 hours Was it administered (AE): yes Previous temperature excursion: yes, 47°F to 77°F {71F) for 62 hours. No adverse symptoms reported.
1) pox-trunk & face -maculopapular rash 2) Arms, legs, buttocks - urticaria Diphenhydramine Q4-5 hours Afebrile, normal behavior
Shortness of Breath; Asthma; Cough; he is experiencing asthma, shortness of breath and a cough/he has had these symptoms previously but it was cleared up and then he had the shot and it hit him again last night; This is a spontaneous report from a contactable consumer (patient). A 76-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL9262, expiry date: May2021), via an unspecified route of administration on the left arm, on 28Jan2021 08:10, at single dose, for COVID-19 immunization, at the hospital. Medical history included cholesterol, blood pressure, coronary artery bypass in 2008, asthma, shortness of breath and cough which the patient already had before receiving the vaccine. Ongoing concomitant medications included rosuvastatin calcium (CRESTOR) for cholesterol and losartan for blood pressure. The patient did not receive any prior vaccinations within four weeks. On 01Feb2021, the patient experienced asthma, shortness of breath and cough. The patient stated that he already had these symptoms before receiving the vaccine and clarified he has had these symptoms previously, but it was cleared up and then he had the shot and it hit him again. He added that last night, on 01Feb2021, he had to sit in a chair all night due to the coughing. He did take some albuterol in his nebulizer and he was better on 02Feb2021. He was asking if he can take prednisone between doses of the Pfizer COVID 19 vaccine. His second dose was scheduled on 19Feb2021. The events did not require visit to a physician or emergency room. The outcome of the events was recovering.
Pt was given vaccine and was feeling okay  but then witnessed someone else receive theirs he then began to feel lightheaded, clammy and hot. He said the next thing he remembers he was waking up on the ground, he denies hitting his head. Heart rate was 65 after the episode, patient appears pale, at time of presentation bp 127/62, HR 77 and Spo2 97%. reports feeling better after drinking water and resting in wheelchair. Color improved and he denies signed and symptoms with further monitoring. Patient stated that he passes out every time he receives an injection or has blood drawn. Blood pressure prior to be released from observation was 118/66 HR 67and Sp02 98% . Patient was taken to exit via wheelchair and ambulated to his car.
Tiredness; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Tiredness) in a 74-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040A2119) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced FATIGUE (Tiredness). At the time of the report, FATIGUE (Tiredness) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment medication were provided. No concomitant medication were provided. Patient called in for the help in scheduling his second shot on 06th Apr 2021.
Localized sweling, lump, redness, painful areas in groin. Right thigh area
Pt. c/o swelling, pain at injection site. Seen in office, 4" circle erythema, warm, tender told to monitor and call if sx change, worsen.
flu like symptoms; This is a spontaneous report from a contactable consumer or other non hcp (patient friend). A patient of unspecified age and gender received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 2 via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as 2ND DOSE, SINGLE DOSE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient previously took first dose of bnt162b2 on an unspecified date for covid-19 immunisation. On an unspecified date, after vaccination the patient experienced flu like symptoms. The outcome of the event was unknown.  Information on the lot/batch number has been requested
Information has been received from a nurse practitioner concerning a 24 year old female with no pertinent medical history reported and no known drug allergies who on 27-JUN-2008 was vaccinated with first dose of GARDASIL (lot number 660393/0067X). Concomitant therapy included birth control (name unspecified). The nurse practitioner reported that on her annual exam of this year (2009) the office noticed that the patient the rest of the series of GARDASIL. The patient stated that was because of the experienced she had after receiving the first dose. The nurse practitioner reported that immediately after receiving the first dose on 27-JUN-2008, the patient experienced flu-like symptoms, shortness of breath, nausea, vomiting, and her arm was sore; her shoulder locked up and had a severe migraine. It was reported that the symptoms lasted for about two days. The nurse practitioner reported that the patient had now recovered. No lab tests were performed. The patient sought medical attention by calling the physician. Additional information has been requested.
The pt received a HBV injection. At time of injection, the pt complained that she felt a burning pain at the site. Three hours later, she noted pain at site, hard area, redness. Symptoms continued to worsen, and was unable to lift arm. At time of reporting, 8x10cm indurated, hot to touch, painful with palpation noted.
Given immunizations on 12/17/07, parent states child's lips, eye, ears, and throat began to swell approximately 4 hrs after immun. She sates red rash on body and face. Take to ER, was given a steroid shot and Benadryl. Stayed for 4 hrs before being released once swelling and rash started to subside.
First dose yielded a rash on arm for one week, one week later. Second dose- had chills, diarrhea, dizzy, fainted, very bad asthma
On 10/20/2021, I went for my Pzifer booster shot as instructed by my doctors.  I had a fever for five days, extreme chills and shaking of my body.  The blood in my urine appeared on 10/22/2021. I immediately contacted my primary care physician, who tested my urine and did blood work to test my kidney function.   I had gross hematuria and proteinuria found in my urine.  Due to my history of both cancer and auto immune issues, my PCP sent me to a nephrologist and urologist.
Missed second dose; I got the vaccine the first week of may but I got COVID next week of May; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Missed second dose) and SUSPECTED COVID-19 (I got the vaccine the first week of may but I got COVID next week of May) in a 38-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 004C21A) for COVID-19 vaccination.     The patient's past medical history included Accident (Have had left knee operated for 12 days and torn anterior cruciate ligament and meniscus) on 29-Jun-2021.    On 06-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In May 2021, the patient experienced SUSPECTED COVID-19 (I got the vaccine the first week of may but I got COVID next week of May). On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (Missed second dose). At the time of the report, PRODUCT DOSE OMISSION ISSUE (Missed second dose) had resolved and SUSPECTED COVID-19 (I got the vaccine the first week of may but I got COVID next week of May) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 17-May-2021, SARS-CoV-2 test: positive (Positive) Positive..         No concomitant medications was provided by the reporter. No treatment was provided by the reporter.   Most recent FOLLOW-UP information incorporated above includes: On 25-Jul-2021: Patient Details and Medical history provided On 25-Jul-2021: Translation document received containing No new nformation On 30-Jul-2021: follow up received contain no new information
depression and anxiety, burning in chest, extreme fatigue, sleep issues, intense musculoskeletal pain only at site of previous injury/surgery.  ALL symptoms lasted for about 10 weeks.
Received Moderna COVID vaccines on 2/5/2021 and 3/5/2021 Hospitalized with COVID and pneumonia on 8/21/2021
About 5 minutes after vaccination patient complained of sharp back pain. Patient taken by ambulance to emergency room. Patient returned about 4 hours later and stated she was ok.
Within 16 hours of getting the vaccination, I developed uncontrollable shivers, had a headache, reached a fever of 104.2
Patient received first Johnson and Johnson, 2 minutes into a 30 min observation, patient began to have seizure like activity.  Patient's eyes rolled back and he started to quickly shake for about 1 minute.  Patient came to and was responsive.  Provider arrived, vitals and physical exam were within normal limits.   Patient was recommended to schedule an appointment with PCP and ask for a referral to Neurology, since patient had seizure like activity with a Tdap a few years ago.
Janssen on 4/8. Positive on 8/29 admitted on 8/29-current
Body aches, muscle pain first, then patient slept for one to two hours, then awoke with a headache and fever. These symptoms lasted through the night. Pt felt very fatigued, and slept through the next morning. When symptoms persisted through the afternoon of 10/21/10, the pt decided to call ER. After onset, the symptoms were stable. Pt denies taking medicines to try to relieve her symptoms.
Very bad pain in feet; Can barely walk; This case was reported by a consumer and described the occurrence of foot pain in a 60-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Concurrent medical conditions included ulcerative colitis. Concomitant products included upadacitinib (Rinvoq).   On 22nd August 2022, the patient received Shingrix. On 9th September 2022, 18 days after receiving Shingrix, the patient experienced foot pain and walking difficulty. On an unknown date, the outcome of the foot pain and walking difficulty were not recovered/not resolved.   It was unknown if the reporter considered the foot pain and walking difficulty to be related to Shingrix.     Additional Information: GSK Receipt Date: 25-JAN-2023 Reporter's Comments: The patient self-reported this case. The patient reported that ever since she got the Shingrix shot she had been having very bad pain in her feet that moves around.  The patient said sometimes it was so bad she could barely walk. (Foot pain). The patient said symptoms were not treated.  The reporter was consented to follow up.
tingling in hands and feet; itchiness in hands and feet; can't sleep every night since got vaccine; This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA (tingling in hands and feet), PRURITUS (itchiness in hands and feet) and INSOMNIA (can't sleep every night since got vaccine) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination.     Concomitant products included ALUMINIUM HYDROXIDE GEL, DRIED, MAGNESIUM CARBONATE (PEPCID [ALUMINIUM HYDROXIDE GEL, DRIED;MAGNESIUM CARBONATE]) and SIMETHICONE for GERD, Amlodipine                                                     for Blood pressure for Hypertension.    On 20-Jan-2021 at 3:00 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Jan-2021, the patient experienced PARAESTHESIA (tingling in hands and feet), PRURITUS (itchiness in hands and feet) and INSOMNIA (can't sleep every night since got vaccine). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency and PARACETAMOL (TYLENOL) on 02-Feb-2021 at a dose of 1 dosage form. At the time of the report, PARAESTHESIA (tingling in hands and feet), PRURITUS (itchiness in hands and feet) and INSOMNIA (can't sleep every night since got vaccine) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.; Sender's Comments: Based on the current available information which shows a temporal association between the use of mRNA-1273 and the onset of the events, a causal relationship cannot be excluded.
Rash on neck/Rash on neck, eyelids and around mouth; Rash on neck, eyelids; This case was reported by a consumer via call center representative and described the occurrence of rash in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 2nd August 2019, the patient received the 1st dose of Shingrix (intramuscular) .5 ml. On 3rd August 2019, 1 days after receiving Shingrix, the patient experienced rash and eyelid rash. On an unknown date, the outcome of the rash and eyelid rash were unknown.   It was unknown if the reporter considered the rash and eyelid rash to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported.  Less than a year, a year after receiving the 1st dose of Shingrix the patient experienced rash on her neck, eyelids and around her mouth. For tolerance to 2nd dose refer linked case US2020AMR093219, reported by the same reporter. The reporter did consent to follow up.; Sender's Comments:  US-GLAXOSMITHKLINE-US2020AMR093219:Same patient; 2nd dose
gotten a bunch of mole on arms now on legs/moles showing up on her legs/on her shoulders/on her back; a cyst on right arm; This is a spontaneous report from a contactable consumer (patient) from a Pfizer-sponsored program. This 57-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration in the right arm on 09Apr2021 at age of 56 years old as single dose for COVID-19 immunisation. Medical history and concomitant medications were unknown. The patient received the first dose of the Pfizer 09Apr2021 and the second dose on 07May2021 in her right arm (Lot # EW0182) and since 1st dose had gotten a bunch of mole on arms currently on legs. She got a bunch of moles on her arms and they were spreading to her legs after she received the Covid 19 vaccine. She was seen by her family doctor and her doctor said they were moles and cysts.  MD told her they were harmless but also noticed a cyst on right arm. She felt like the moles were going overtake her body and looked like crap, more mole were going to keep appearing. She was going to see a dermatologist in a month.The patient was looking information on reports of moles and cysts. She had asked her doctor for a referral to a dermatologist and she knew her doctor was concerned also. She started to notice the moles and cysts about 3 to 3.5 months ago and that corresponded with the first vaccine. When probing medical history and concomitant medications she reports nothing was relevant. She wasn't taking any new medications. She can't remember exactly when she saw her doctor. She had seen her doctor a couple of times. Both times she's asked her doctor about the moles because they were concerning her. The last time she saw her doctor was 12Jul2021 and that was a follow up so she saw her doctor a month before that maybe around 12Jun2021. She would have mentioned the moles to her doctor at that first appointment in Jun2021. The moles appeared first on her arms and she didn't think it was one arm more than the other. She felt like the moles could end up overtaking her body, she looked like crap. The doctor said they were moles and one was a cyst. The moles were still showing up, showing up on her legs and shoulders, and back as far as she can tell. Her cyst was on her right arm. Her doctor looked at the moles and said there was nothing wrong. Event required visit to Physician Office. Outcome of the events was not recovered.   The lot number for the vaccine, BNT162b2 , was not provided and will be requested during follow up.